earli
manifest
coccidioidomycosi
valley
fever
similar
caus
communityacquir
pneumonia
cap
without
specif
etiolog
test
true
frequenc
valley
fever
may
underestim
public
health
statist
therefor
conduct
prospect
observ
studi
adult
recent
onset
lower
respiratori
tract
syndrom
valley
fever
serolog
confirm
person
confid
interv
antimicrobi
medic
use
person
valley
fever
symptomat
differ
time
enrol
insuffici
predict
valu
valley
fever
guid
clinician
without
specif
laboratori
test
thu
valley
fever
common
caus
cap
exposur
diseaseendem
region
cap
develop
person
travel
resid
coccidioidesendem
region
diagnost
evalu
routin
includ
laboratori
evalu
organ
c
occidioidomycosi
valley
fever
infect
caus
coccidioid
immiti
coccidioid
posadasii
fungi
endem
part
arizona
california
utah
new
mexico
texa
mexico
elsewher
central
south
america
common
clinic
syndrom
result
infect
communityacquir
pneumonia
cap
character
system
ill
lower
respiratori
tract
symptom
variou
immunolog
manifest
rash
skelet
discomfort
syndrom
occur
week
inhal
fungal
spore
may
present
protract
period
although
infect
occasion
spread
hematogen
part
bodi
infect
eventu
resolv
without
complic
specif
antifung
therapi
enorm
dispar
exist
predict
number
ill
caus
coccidioid
infect
actual
number
infect
report
state
depart
public
health
exampl
rate
skin
test
convers
size
suscept
popul
southern
arizona
indic
ill
develop
person
per
year
similar
frequenc
obtain
indirect
analys
estim
accur
coccidioidomycosi
would
common
caus
cap
diseaseendem
region
contrast
case
report
arizona
depart
health
servic
averag
annual
fewer
estim
figur
best
reflect
actual
frequenc
ill
profound
implic
diagnost
evalu
therapeut
manag
patient
exposur
coccidioid
speci
diseaseendem
region
report
present
result
evalu
patient
seek
care
symptom
cap
respect
incid
coccidioidomycosi
cap
often
manag
clinician
part
gener
medic
practic
chose
set
studi
find
provid
first
prospect
evid
coccidioidomycosi
common
caus
cap
studi
area
addit
relev
result
resid
within
coccidioidesendem
region
similar
risk
coccidioid
infect
expect
other
cap
recent
travel
histori
coccidioidesendem
area
medic
center
medic
offic
arizona
commun
physician
recruit
conduct
time
period
decemb
februari
may
august
although
sought
enrol
mani
elig
person
possibl
period
studi
personnel
alway
avail
elig
enrol
patient
exhibit
lower
respiratori
syndrom
month
durat
includ
follow
pleurit
chest
pain
dyspnea
exert
evalu
chest
radiograph
multipl
visit
respiratori
problem
administr
antibacteri
drug
presum
cap
patient
exclud
enrol
previous
diagnos
laboratoryconfirm
coccidioid
infect
anoth
laboratoryconfirm
diagnosi
inclusiondefin
ill
year
age
previou
exposur
week
diseaseendem
area
fewer
patient
offer
enrol
refus
particip
studi
observ
studi
medic
manag
patient
condit
remain
entir
respons
clinician
inform
consent
obtain
person
interview
clinic
record
review
collect
inform
regard
demograph
comorbid
condit
time
rang
exposur
diseaseendem
region
recent
antimicrobi
therapi
current
respiratori
ill
person
ask
complet
medic
outcom
studi
short
form
health
survey
iowa
fatigu
scale
respiratori
infect
sever
scale
result
chest
radiograph
complet
blood
count
obtain
part
routin
medic
care
also
record
second
visit
schedul
person
serum
sampl
obtain
visit
store
test
complet
studi
person
identifi
coccidioid
infect
also
contact
within
next
month
determin
statu
ill
anticoccidioid
antibodi
measur
laboratori
author
jng
sever
convent
method
doubl
immunodiffus
techniqu
use
measur
tube
precipitintyp
complement
fixingtyp
anticoccidioid
antibodi
serum
sampl
qualit
posit
complement
fixingtyp
anticoccidioid
antibodi
retest
quantit
anticoccidioid
immunoglobulin
igm
igg
antibodi
measur
enzymelink
immunoassay
use
commerci
kit
accord
manufactur
instruct
coccidioid
eiagold
meridian
diagnost
cincinnati
oh
usa
optic
densiti
consid
posit
rel
sensit
test
patient
coccidioid
pneumonia
previous
analyz
patient
laboratori
data
enter
databas
access
microsoft
corp
bellingham
wa
usa
statist
analysi
accomplish
sa
version
sa
institut
inc
cari
nc
usa
differ
group
categor
variabl
compar
test
continu
variabl
compar
wilcoxon
signrank
test
wilcoxon
ranksum
test
appropri
differ
p
valu
consid
signific
person
enrol
studi
provid
serum
sampl
baselin
exclud
analysi
fiftyf
percent
enrolle
male
median
age
year
interquartil
rang
year
tabl
person
nonhispan
white
reflect
demograph
studysit
sampl
patient
lower
respiratori
syndrom
median
addit
inclus
criteria
individu
criteria
evalu
chest
radiograph
administr
antimicrobi
drug
dyspnea
exert
pleurisi
multipl
visit
condit
person
provid
serum
sampl
baselin
provid
second
serum
sampl
day
later
median
day
person
posit
serolog
test
confid
interv
ci
baselin
posit
multipl
assay
posit
result
multipl
serolog
test
serum
sampl
tabl
remain
person
neg
result
test
baselin
second
serum
sampl
obtain
person
also
nonreact
demograph
result
person
without
valley
fever
shown
tabl
length
exposur
diseaseendem
area
significantli
shorter
patient
valley
fever
seroneg
p
odd
ratio
develop
coccidioidomycosi
person
exposur
year
diseaseendem
area
compar
longer
exposur
time
ci
signific
demograph
differ
identifi
group
twenti
particip
age
rang
year
year
year
respect
percentag
particip
age
group
valley
fever
respect
respiratori
system
musculoskelet
symptom
shown
tabl
myalgia
show
signific
differ
group
survey
respiratori
infect
sever
scale
identifi
addit
differ
howev
iowa
fatigu
scale
survey
median
product
domain
score
maximum
score
indic
greatest
reduct
person
valley
fever
compar
person
p
proport
patient
chest
radiograph
obtain
similar
seroposit
seroneg
patient
vs
howev
chest
radiograph
obtain
n
abnorm
significantli
frequent
particip
valley
fever
vs
p
radiograph
abnorm
associ
coccidioid
infect
includ
pulmonari
infiltr
hilar
adenopathi
particip
person
seen
primari
care
set
prescrib
antimicrobi
medic
receiv
consecut
cours
treatment
receiv
consecut
cours
treatment
differ
seen
seroposit
seroneg
group
either
proport
treat
antimicrobi
drug
vs
proport
treat
multipl
cours
drug
vs
person
improv
month
enrol
receiv
specif
antifung
therapi
oral
fluconazol
month
none
requir
hospit
eleven
person
valley
fever
repeat
symptom
survey
iowa
fatigu
scale
median
day
enrol
respons
indic
signific
improv
cough
p
fatigu
p
cognit
p
energi
p
product
p
similar
improv
note
survey
iowa
fatigu
scale
readminist
person
followup
visit
patient
enrol
prospect
studi
select
ambulatori
care
set
within
diseaseendem
region
diagnos
serolog
coccidioidomycosi
even
one
take
account
wide
ci
number
demonstr
high
proport
cap
caus
infect
furthermor
although
serolog
test
use
diagnosi
highli
specif
coccidioid
infect
anoth
studi
emphas
first
week
primari
ill
test
frequent
show
neg
result
current
studi
particip
initi
serolog
posit
coccidioid
antibodi
second
serum
sampl
twentyseven
person
serolog
neg
enrol
return
retest
thu
addit
coccidioid
infect
may
identifi
group
result
like
provid
underestim
incid
group
patient
strengthen
conclus
valley
fever
common
caus
cap
person
expos
coccidiod
diseaseendem
area
high
frequenc
valley
fever
caus
cap
found
studi
consist
previou
estim
coccidioidomycosi
domin
caus
cap
exposur
diseaseendem
area
similar
estim
obtain
retrospect
southern
arizona
veteran
administr
health
care
system
tucson
arizona
convers
diagnosi
valley
fever
requir
laboratori
test
practic
may
uniform
among
clinician
shown
retrospect
analysi
physicianspecif
diagnos
primari
care
clinic
tucson
arizona
rate
diagnos
coccidioidomycosi
vari
among
physician
within
group
practic
similar
differ
might
also
account
increas
case
rate
associ
patient
age
report
recent
analysi
arizona
state
statist
case
rate
person
year
age
nearli
twice
person
year
age
studi
person
uniformli
evalu
valley
fever
age
group
similar
rate
furthermor
although
detail
result
sever
ill
term
respiratori
symptom
less
elderli
subject
interpret
differ
state
statist
studi
indic
older
person
develop
ill
like
exact
diagnosi
determin
underscor
underreport
ill
patient
group
young
adult
corollari
high
frequenc
coccidioidomycosi
seen
studi
person
anywher
cap
histori
recent
travel
southcentr
arizona
region
coccidioidomycosi
highli
endem
would
expect
similarli
high
risk
reason
obtain
travel
histori
patient
cap
essenti
earli
accur
diagnosi
diseas
well
region
problem
sever
acut
respiratori
syndrom
sar
hantaviru
pneumonia
avian
influenza
although
infecti
diseas
societi
america
practic
guidelin
cap
current
recommend
obtain
complet
travel
histori
patient
refractori
pneumonia
recommend
guidelin
revis
recommend
obtain
travel
histori
first
evalu
analysi
multipl
symptom
baselin
show
sever
characterist
associ
coccidioid
infect
shorter
length
exposur
diseaseendem
region
greater
frequenc
radiograph
abnorm
seen
person
valley
fever
compar
without
valley
fever
associ
also
evid
previou
report
univers
health
center
symptom
myalgia
reduc
product
also
evid
coccidioid
infect
howev
none
associ
alon
combin
suffici
magnitud
assist
clinician
initi
diagnosi
therefor
find
previou
studi
emphas
laboratori
test
initi
physician
visit
essenti
identifi
patient
symptom
cap
caus
valley
fever
high
proport
person
valley
fever
prescrib
initi
cours
antimicrobi
drug
patient
diagnos
valley
fever
receiv
cours
drug
although
diagnosi
valley
fever
serolog
method
frequent
delay
day
use
antimicrobi
drug
could
still
avoid
stop
earlier
patient
whose
ill
determin
caus
coccidioid
speci
inclus
criteria
use
studi
design
broadli
inclus
select
patient
sever
ill
differ
respect
commonli
use
entri
criteria
clinic
trial
new
antimicrobi
drug
treatment
cap
exampl
chose
pleurit
chest
pain
dyspnea
rest
fever
entri
requir
use
entri
criteria
found
patient
valley
fever
underw
radiograph
examin
normal
radiograph
consist
result
previou
studi
adher
infecti
diseas
societi
america
american
lung
associ
definit
pneumonia
compar
find
studi
way
patient
select
taken
account
sever
limit
method
deserv
emphasi
inclus
criteria
standard
comparison
result
studi
cap
difficult
also
diagnosi
patient
without
valley
fever
sinc
rel
small
studi
addit
expand
studi
may
use
especi
extend
observ
group
children
elderli
requir
hospit
resid
elsewher
within
diseaseendem
region
futur
studi
also
need
determin
best
practic
manag
primari
coccidioid
infect
possibl
therapi
specif
antifung
treatment
high
proport
cap
caus
coccidioid
speci
provid
impetu
conduct
studi
